Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exact Sciences Cor (NQ: EXAS ) 58.85 +0.06 (+0.10%) Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Exact Sciences Cor < Previous 1 2 Next > Exact Sciences Names Aaron Bloomer as New Chief Financial Officer April 15, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes April 11, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 April 08, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Schedules First Quarter 2024 Earnings Call April 08, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment April 04, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer March 28, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner March 27, 2024 From Exact Sciences Corp. Via Business Wire The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study March 13, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer March 07, 2024 From Exact Sciences Corp. Via Business Wire 3 Hot Stocks Bought by Members of Congress: Follow the Money March 01, 2024 Palo Alto Networks, Simon Property Group and JPMorgan Chase are the top three stocks bought by Members of Congress in February; Via MarketBeat Exact Sciences to Participate in March Investor Conference February 26, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Announces Fourth Quarter 2023 Results February 21, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Schedules Fourth Quarter 2023 Earnings Call February 01, 2024 From Exact Sciences Corp. Via Business Wire Time to buy these 3 healthcare companies that raised revenue guidance? January 16, 2024 The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance. Via MarketBeat Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience September 12, 2023 From Agilent Technologies Inc. Via Business Wire ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF July 13, 2023 If you're a believer in the progress of science and technology and feel strongly that our best days are still ahead, then a slice of ARKK could be tempting. Via MarketBeat Topics ETFs Economy Exposures Interest Rates Analysts Bullish On Exact Sciences' Advanced Cancer Screening June 23, 2023 Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product. Via MarketBeat MarketBeat Week in Review – 5/15 - 5/19 May 20, 2023 Investors are battling stagflation as they wait for a recession, and the MarketBeat team continues to help you understand where to find opportunities Via MarketBeat Topics Economy Electric Vehicles Exposures Economy Electric Vehicles Interest Rates Exact Sciences Serves Investors Exactly What They Wished For May 15, 2023 Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The Via MarketBeat A New Groundbreaking Tool to Detect Colon Cancer Earlier May 10, 2023 A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This... Via PressReach Exposures Product Safety New Artificial Intelligence Tool Can Diagnose Colon Cancer May 03, 2023 A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and... Via PressReach Topics Artificial Intelligence Death Exposures Artificial Intelligence Death Product Safety Is Biotech Immunocore About To Make A 25% Price Move? February 07, 2023 Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher. Via MarketBeat Topics ETFs Cathie Woods' Ark Innovation ETF Set To Rebound in 2023? February 02, 2023 Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023? Via MarketBeat Topics ETFs Cathie Wood Is Buying These Stocks, Should You? January 18, 2023 Cathie Wood is known for her deep understanding of tech companies and for holding aggressive long positions in her tech funds. Let's look at what she's buying. Via MarketBeat Topics ETFs Exact Sciences Corp Stock Price Is Trending Up Here's Why January 10, 2023 Exact Science's stock price is shooting higher this week amid posting upward revisions for its revenue and earnings estimates for this quarter. Via MarketBeat Is Illumina Still the Gamechanger in Genomics Sequencing? October 04, 2022 Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused Via MarketBeat Topics Earnings Economy Lawsuit Exposures Financial Legal Supply Chain Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors September 29, 2022 Via AB Newswire Billions Flowing into Cancer Immunotherapy as Market Responds to Impressive Market Potential January 24, 2022 FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 24, 2022 – USA News Group – Within the grand battle against cancer, the use of immunotherapy continues to grow at... Via FinancialNewsMedia Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer February 02, 2022 Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials... Via FinancialNewsMedia Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods December 01, 2021 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – December 1, 2021 – Early onset colorectal cancer is currently on the rise [[1]], according to a new study [[2]] from the... Via FinancialNewsMedia < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.